Work

Pharmacokinetics, Safety, and Tolerability of Letermovir Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Subjects

Year: 2022

Type: article

Study design: Clinical Trial

Source: Clinical Pharmacology in Drug Development

DOI: 10.1002/cpdd.1081

Authors: Kazuhiko Asari, Mikio Ishii, Hiroyuki Yoshitsugu, Akira Wakana, Craig Fancourt, Esther Yoon, Kenichi Furihata, Jacqueline B. McCrea, S. Aubrey Stoch, Marian Iwamoto

Institutions: MSD K.K. (Japan), Merck & Co., Inc., Rahway, NJ, USA (United States), PAREXEL International (United States)

Language: English

Topic: Cytomegalovirus and herpesvirus research

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Merck Sharp and Dohme

OpenAlex ID: W4214848147

FWCI: 1.373

Cites: 33

Cited by: 11

Related to: 10